Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    2020 dividend forecasts: BP, Vodafone and Astrazeneca

    | Paul Summers

    Paul Summers takes a look at what income investors might expect from three FTSE 100 (INDEXFTSE:UKX) favourites next year.

    Read more »

    Investing Articles

    Investing £10k in index funds vs FTSE 100 stocks

    | Kirsteen Mackay

    I think diversification is the key to a lower risk financial portfolio.

    Read more »

    Investing Articles

    This FTSE 100 giant is up 30% in six months! Here’s what I’d do now

    | Conor Coyle

    Conor Coyle evaluates whether this pharma favourite can see continued growth.

    Read more »

    Investing Articles

    Forget Premium Bonds! I’d make a passive income with these 2 FTSE 100 dividend shares

    | Peter Stephens

    These two FTSE 100 (INDEXFTSE:UKX) shares could offer improving income outlooks in my view.

    Read more »

    Investing Articles

    Why I think the AstraZeneca share price can double your money

    | Alan Oscroft

    Despite its troubles, the AstraZeneca (LON: AZN) share price has soared over 10 years, but is that set to repeat?

    Read more »

    Investing Articles

    What next for the AstraZeneca share price?

    | Karl Loomes

    With rising revenue and increased sales forecasts, what comes next for AstraZeneca shares?

    Read more »

    Investing Articles

    The elephant in the room with AstraZeneca’s latest update

    | G A Chester

    The AstraZeneca share price jumped over 5% on a trading update last week, but there's a big reason to avoid…

    Read more »

    Investing Articles

    Forget Brexit! Another FTSE 100 dividend stock I think is a top buy whatever happens

    | Royston Wild

    The never-ending Brexit saga makes the investing environment very testing for share pickers. I'd take the tension away by buying…

    Read more »

    Investing Articles

    Is it too late to buy shares in AstraZeneca?

    | T Sligo

    With news that the AstraZeneca stock price is on the rise, and its low dividend, is it worth buying the…

    Read more »

    Investing Articles

    The AstraZeneca share price is rising fast. Here’s what I’d do now

    | Manika Premsingh

    FTSE 100 pharmaceuticals giant AstraZeneca turned in a good set of results. Is it time to buy right now?

    Read more »

    Investing Articles

    What happened in the stock market today

    | Stepan Lavrouk

    AstraZeneca (LON: AZN) reports strong earnings, RBS (LON: RBS) is hit by a PPI charge, and Woodford Patient Capital (LON:…

    Read more »

    Retirement Articles

    I believe FTSE 100 stock AstraZeneca is set to deliver strong growth and dividends

    | Kevin Godbold

    New medicines deliver “impressive” results from AstraZeneca’s key markets, such as China, the US and Japan.

    Read more »